Tone mix
Week by week 51 weeks
Share of Xenon Pharmaceuticals Inc's 141 headlines over the last 52 weeks by the model's call, and the same mix week by week.
Biggest swings in the last year
The weeks whose tone moved furthest from the 8-week average, with the story most outlets carried that week.
- Week of Aug 18, 2025 · tone -100FY2025 EPS Estimates for XENE Decreased by Analyst-120
- Week of Jul 14, 2025 · tone +100Xenon Pharmaceuticals Inc. (NASDAQ:XENE) Receives Average Recommendation of "Buy" from Brokerages+86
- Week of Dec 15, 2025 · tone +100Xenon Pharmaceuticals Inc. (NASDAQ:XENE) Receives Average Rating of "Buy" from Analysts+83
- Week of May 25, 2026 · tone +100JPMorgan Raises its Price Target on Xenon Pharmaceuticals (XENE)+62
- Week of Apr 20, 2026 · tone +99Xenon Pharmaceuticals Inc (XENE) Looking At a $2 Billion Opportunity Here+58
- Week of Mar 23, 2026 · tone +90Brokerages Set Xenon Pharmaceuticals Inc. (NASDAQ:XENE) Price Target at $71.88+57
Daily headline tone, last 90 sessions
Hover a session for its totals; click to pin.
Each point is the average score of the headlines about Xenon Pharmaceuticals Inc in one trading session, with the 8-session average drawn through it. Sessions with no headline about the company have no point.
Tone by period
Show the table · 3 rows, 3 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Last 7 sessions | 0 | No headlines |
| Last 30 sessions | 18 | -33 |
| Last 90 sessions | 35 | -9 |
No matching rows. Clear the filter to see all records.
Every headline in the period counts equally.
Headlines on Monday, October 19, 2026
1 headline, average tone 0: 0 positive, 1 neutral and 0 negative. Showing all 1.
- www.dailypolitical.com · 1 outletContrasting Xenon Pharmaceuticals (NASDAQ:XENE) and United Therapeutics (NASDAQ:UTHR)Neutral
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Contrasting Xenon Pharmaceuticals (NASDAQ:XENE) and United Therapeutics (NASDAQ:UTHR) | www.dailypolitical.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Wednesday, October 14, 2026
1 headline, average tone -99: 0 positive, 0 neutral and 1 negative. Showing all 1.
- www.tickerreport.com · 1 outletXenon Pharmaceuticals (NASDAQ:XENE) Cut to "Strong Sell" at Wall Street ZenNegative
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Xenon Pharmaceuticals (NASDAQ:XENE) Cut to "Strong Sell" at Wall Street Zen | www.tickerreport.com | 1 | Negative |
No matching rows. Clear the filter to see all records.
Headlines on Monday, October 12, 2026
1 headline, average tone 0: 0 positive, 1 neutral and 0 negative. Showing all 1.
- www.themarketsdaily.com · 1 outletHead to Head Survey: Xenon Pharmaceuticals (NASDAQ:XENE) vs. United Therapeutics (NASDAQ:UTHR)Neutral
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Head to Head Survey: Xenon Pharmaceuticals (NASDAQ:XENE) vs. United Therapeutics (NASDAQ:UTHR) | www.themarketsdaily.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Tuesday, October 6, 2026
1 headline, average tone +81: 1 positive, 0 neutral and 0 negative. Showing all 1.
- www.dailypolitical.com · 1 outletXenon Pharmaceuticals Inc. (NASDAQ:XENE) Stock Has Average Target Price of $70.27Positive
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Xenon Pharmaceuticals Inc. (NASDAQ:XENE) Stock Has Average Target Price of $70.27 | www.dailypolitical.com | 1 | Positive |
No matching rows. Clear the filter to see all records.
Headlines on Monday, October 5, 2026
2 headlines, average tone 0: 0 positive, 2 neutral and 0 negative. Showing all 2.
- www.chathamdailynews.ca · 6 outletsXenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)Neutral
- www.themarketsdaily.com · 1 outletXenon Pharmaceuticals (NASDAQ:XENE) CEO Purchases $1,121,400.00 in StockNeutral
Show the table · 2 rows, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | www.chathamdailynews.ca | 6 | Neutral |
| Xenon Pharmaceuticals (NASDAQ:XENE) CEO Purchases $1,121,400.00 in Stock | www.themarketsdaily.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
How the score works
A headline's tone is not a forecast of the share price. Read the headlines themselves before acting on an average.
Which headlines count
Headlines come from the GDELT global news feed from 2019-09-23 on. A headline counts only when a model judges it to be about Xenon Pharmaceuticals Inc, not a passing mention.
How each headline is scored
The model calls each headline positive, neutral or negative news for the company. A period's tone is the share of positive minus negative headlines, from -100 (all negative) to +100 (all positive).
When a headline counts
Headlines published by 9:15 a.m. New York time belong to that day's session. Later and weekend headlines move to the next trading session.
Repeated stories
When several outlets carry the same headline, it counts once per session.